Rankings
▼
Calendar
AMRX FY 2014 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
FY 2014 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$786M
Gross Profit
$450M
57.2% margin
Operating Income
$223M
28.4% margin
Net Income
$177M
22.5% margin
EPS (Diluted)
$0.94
Cash Flow
Operating Cash Flow
$112M
Free Cash Flow
$33M
Stock-Based Comp.
$0
← FY 2015
All Quarters
